array:24 [ "pii" => "S2387020621006926" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.03.029" "estado" => "S300" "fechaPublicacion" => "2022-01-21" "aid" => "5621" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:93-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775321001470" "issn" => "00257753" "doi" => "10.1016/j.medcli.2021.03.002" "estado" => "S300" "fechaPublicacion" => "2022-01-21" "aid" => "5621" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:93-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Vacunas: un bien público universal" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "93" "paginaFinal" => "94" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Vaccines: A universal public good" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jaume Padrós Selma" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jaume" "apellidos" => "Padrós Selma" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020621006926" "doi" => "10.1016/j.medcle.2021.03.029" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006926?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321001470?idApp=UINPBA00004N" "url" => "/00257753/0000015800000002/v1_202201120526/S0025775321001470/v1_202201120526/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020621006938" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.03.030" "estado" => "S300" "fechaPublicacion" => "2022-01-21" "aid" => "5679" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:94-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Bradycardia due to remdesivir: Report of two cases" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "94" "paginaFinal" => "95" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Bradicardia por remdesivir: estudio de dos casos" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Cebrián Lara, Eva Hernàndez Lorente, Paula García Llopis" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Cebrián Lara" ] 1 => array:2 [ "nombre" => "Eva" "apellidos" => "Hernàndez Lorente" ] 2 => array:2 [ "nombre" => "Paula" "apellidos" => "García Llopis" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775321002438" "doi" => "10.1016/j.medcli.2021.03.030" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321002438?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006938?idApp=UINPBA00004N" "url" => "/23870206/0000015800000002/v1_202201220701/S2387020621006938/v1_202201220701/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020621006884" "issn" => "23870206" "doi" => "10.1016/j.medcle.2021.03.027" "estado" => "S300" "fechaPublicacion" => "2022-01-21" "aid" => "5657" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;158:93" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Treatment of Graves' ophthalmopathy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "93" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento de la oftalmopatía de Graves" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jaume Alijotas-Reig" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jaume" "apellidos" => "Alijotas-Reig" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775321002219" "doi" => "10.1016/j.medcli.2021.03.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321002219?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006884?idApp=UINPBA00004N" "url" => "/23870206/0000015800000002/v1_202201220701/S2387020621006884/v1_202201220701/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Vaccines: A universal public good" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "93" "paginaFinal" => "94" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Jaume Padrós Selma" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Jaume" "apellidos" => "Padrós Selma" "email" => array:1 [ 0 => "consell@ccmc.cat" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Consell de Col·legis de Metges de Catalunya, Barcelona, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vacunas: un bien público universal" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The Council of Medical Associations of Catalonia (CCMC, <span class="elsevierStyleItalic">Consell de Collegis de Metges de Catalunya</span>) have issued a manifesto titled “Vaccine: a Universal Public Good”, which we would like to reproduce in its entirety below given its interest for all healthcare professionals:</p><p id="par0010" class="elsevierStylePara elsevierViewall">“After one year of the pandemic, everyone is looking hopefully at vaccines, the most effective health intervention we have available to eventually be able to control the 2019 coronavirus disease (COVID-19).</p><p id="par0015" class="elsevierStylePara elsevierViewall">Us health professionals, who live the reality of COVID-19 on a daily basis and are well aware of the consequences of this disease for many citizens, as well as the burden of both pain and suffering it entails, view the vaccination campaign that has just begun as a hopeful reality.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The great role that biomedical research has played in the development of these vaccines deserves our full recognition. It should be remembered that these vaccines are also a reality thanks, in large part, to the public funding of this research.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Despite this, the global production and distribution of anti-COVID-19 vaccines are limited and, therefore, irregular, and uneven, and not everyone will be able to access them. There are many barriers, including patent limitations and a lack of knowledge transfer, to multiplying their global production.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In the face of an unprecedented global crisis, we believe that measures must be taken to respond, over and above any barrier and interest, to public health criteria. The current situation caused by the pandemic and the COVID-19 vaccination process meet all those characteristics of exceptionality, exigible equity, and public health interest required to legitimize the below petition:</p><p id="par0035" class="elsevierStylePara elsevierViewall">From the CCMC, we ask governments and international organizations to establish and apply legal mechanisms that, respecting the basic principle of intellectual property, allow for substantially improving the production and distribution capacity of anti-COVID-19 vaccines, in order to produce the maximum number of doses at the lowest possible cost and to use them as quickly as possible throughout the world.</p><p id="par0040" class="elsevierStylePara elsevierViewall">For all of these reasons, we support and have signed the Vaccine Equity Declaration (<a href="https://www.who.int/campaigns/annual-theme/year-of-health-and-care-workers-2021/vaccine-equity-declaration">https://www.who.int/campaigns/annual-theme/year-of-health-and-care-workers-2021/vaccine-equity-declaration</a>) promoted by the World Health Organization. This initiative calls governments, pharmaceutical companies, regulatory agencies, and world leaders to join forces to accelerate the equitable distribution of vaccines around the world, especially among healthcare workers. We ask all health organizations (professional associations, scientific societies, academic and research institutions, etc.), as well as physicians and other health professionals, to also adhere to this declaration.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In the face of a health threat such as the one that we are currently living, no one is safe until we are all safe. Hence, in this exceptional situation, preserving everyone’s health is the only legitimate goal.”</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Padrós Selma J. Vacunas: un bien público universal. Med Clin (Barc). 2022;158:93–94.</p>" ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015800000002/v1_202201220701/S2387020621006926/v1_202201220701/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015800000002/v1_202201220701/S2387020621006926/v1_202201220701/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006926?idApp=UINPBA00004N" ]
Journal Information
Vol. 158. Issue 2.
Pages 93-94 (January 2022)
Share
Download PDF
More article options
Vol. 158. Issue 2.
Pages 93-94 (January 2022)
Letter to the Editor
Vaccines: A universal public good
Vacunas: un bien público universal
Jaume Padrós Selma
Consell de Col·legis de Metges de Catalunya, Barcelona, Spain
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail